User login
Antiretroviral therapy (ART) regimens provide long-lasting suppression of HIV replication and have helped people with HIV live healthier lives for decades.
Today's ART regimens are associated with fewer serious and intolerable adverse effects than those used in the past, but weight gain remains a concern in clinical practice.
In this ReCAP, Dr David Wohl, from the University of North Carolina at Chapel Hill, reports on the relationship between ART and weight gain, as well as the implications of excessive weight gain in HIV management.
He shares data from multiple studies, including the ADVANCE trial, which offer insight on how different HIV therapies affect patient weight.
Dr Wohl also discusses the steps clinicians should take if weight gain does occur in people who are on HIV therapy.
--
Professor of Medicine; Medical Director, UNC COVID-19 Vaccine Clinic, COVID-19 Monoclonal Antibody Infusion Clinic, University of North Carolina at Chapel Hill
David Wohl, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Gilead; ViiV; Janssen; Merck
Serve(d) as a speaker or a member of a speakers bureau for: Gilead
Received research grant from: Gilead; Merck; ViiV
Antiretroviral therapy (ART) regimens provide long-lasting suppression of HIV replication and have helped people with HIV live healthier lives for decades.
Today's ART regimens are associated with fewer serious and intolerable adverse effects than those used in the past, but weight gain remains a concern in clinical practice.
In this ReCAP, Dr David Wohl, from the University of North Carolina at Chapel Hill, reports on the relationship between ART and weight gain, as well as the implications of excessive weight gain in HIV management.
He shares data from multiple studies, including the ADVANCE trial, which offer insight on how different HIV therapies affect patient weight.
Dr Wohl also discusses the steps clinicians should take if weight gain does occur in people who are on HIV therapy.
--
Professor of Medicine; Medical Director, UNC COVID-19 Vaccine Clinic, COVID-19 Monoclonal Antibody Infusion Clinic, University of North Carolina at Chapel Hill
David Wohl, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Gilead; ViiV; Janssen; Merck
Serve(d) as a speaker or a member of a speakers bureau for: Gilead
Received research grant from: Gilead; Merck; ViiV
Antiretroviral therapy (ART) regimens provide long-lasting suppression of HIV replication and have helped people with HIV live healthier lives for decades.
Today's ART regimens are associated with fewer serious and intolerable adverse effects than those used in the past, but weight gain remains a concern in clinical practice.
In this ReCAP, Dr David Wohl, from the University of North Carolina at Chapel Hill, reports on the relationship between ART and weight gain, as well as the implications of excessive weight gain in HIV management.
He shares data from multiple studies, including the ADVANCE trial, which offer insight on how different HIV therapies affect patient weight.
Dr Wohl also discusses the steps clinicians should take if weight gain does occur in people who are on HIV therapy.
--
Professor of Medicine; Medical Director, UNC COVID-19 Vaccine Clinic, COVID-19 Monoclonal Antibody Infusion Clinic, University of North Carolina at Chapel Hill
David Wohl, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Gilead; ViiV; Janssen; Merck
Serve(d) as a speaker or a member of a speakers bureau for: Gilead
Received research grant from: Gilead; Merck; ViiV
